Last reviewed · How we verify

NCT04785404

Primary Versus Secondary Closure of Stoma-Reversal Skin Wound

Completed NA Last updated 8 July 2021
What this trial tests

NA trial testing primary skin closure in Wound Infection in 50 participants. Completed in 31 December 2020.

Timeline
1 January 2020
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorAyub Teaching Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment50
Start date1 January 2020
Primary completion31 December 2020
Estimated completion31 December 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Ayub Teaching Hospital

Who can join

Eligibility, any sex, with Wound Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

to compare infection rate stoma reversal skin wound after primary or secondary closure

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Primary versus secondary closure of stoma reversal skin wound: Randomized controlled trial.
    Akbar I, Javed Z, Batool N. · · 2023 · PMID 36841997 · DOI 10.47391/jpma.3771

Verify or expand the search:

Other recruiting trials for Wound Infection

Currently open trials in the same condition.

Other Ayub Teaching Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04785404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing